Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.

Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced today the immediate retirement of José ...

On the heels of a major companywide restructuring, Baxter International told investors ... an exercise Almeida said Baxter does every year, is key to keeping the company profitable.

Baxter International (BAX ... to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Baxter International said it weighing the potential impact of the Trump administration's planned tariffs on the medical-products maker's guidance. Baxter on Monday said it stands by its 2025 goals ...

Deerfield-based Baxter International announced Monday that its ... but Almeida said in the release, “With the key elements of our broad strategic transformation complete, this is the right ...

Baxter International announced Monday that its CEO ... but Almeida said in the release, “With the key elements of our broad strategic transformation complete, this is the right time for a ...